Plasma fibrinogen — an independent cardiovascular risk factor
Author:
Open Access
- 1 June 1990
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 227 (6) , 365-372
Abstract
Apart from being an acute phase reactant, fibrinogen appears to play an important although not widely recognized role in athero‐/thrombogenesis. Arteriosclerotic diseases are associated with elevated levels of plasma fibrinogen. Strategies that lower the cardiovascular risk also lower fibrinogen levels. Virtually all accepted risk factors are associated with hyperfibrinogenaemia, while low risk populations usually have low fibrinogen levels. Epidemiological studies show that fibrinogen is a predictor of arteriosclerotic diseases. Its predictive power seems to be as high as or higher than accepted risk factors. These findings and other circumstantial, as well as experimental, evidence suggest that fibrinogen is a powerful, independent cardiovascular risk factor.Keywords
This publication has 94 references indexed in Scilit:
- Blood rheology in patients with transient ischemic attacks.Stroke, 1988
- Fibrinogen as a Risk Factor in Cardiovascular DiseaseNew England Journal of Medicine, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Hemorrheologic changes following acute myocardial infarctionAmerican Heart Journal, 1982
- Whole blood viscosity parameters and cerebral blood flow.Stroke, 1982
- Evidence for Abnormalities in Clotting and Thrombolysis as a Risk Factor For StrokeStroke, 1973
- Stroke and Blood CoagulationStroke, 1973
- Blood viscosity in diabetic childrenDiabetologia, 1971
- Plasma Fibrinogen Patterns in Patients with Coronary AtherosclerosisCirculation, 1966
- Coagulation Tests and Platelet Economy in Atherosclerotic and Control SubjectsCirculation, 1962